Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 7Gynecologic 6Genitourinary 6Gastrointestinal 6Other hematologic neoplasm 3Head & Neck 3Tumor-Agnostic 2CNS 2Breast 2Plasma cell 1Other 1Dermatologic 1Classical hematology 1

Conditions

Skin Neoplasms 1Ectropion 1

Interventions

Ipilimumab 101pembrolizumab 94Nivolumab 87Cyclophosphamide 69fludarabine phosphate 55aldesleukin 52Interleukin-2 39Dacarbazine 35Vemurafenib 31fludarabine 30trametinib 29dabrafenib 29Temozolomide 28Whole-Body Irradiation 21Aminolevulinic Acid 21Carboplatin 20CTLA-4 Antigen 20Bevacizumab 20Radiotherapy 19Peripheral Blood Stem Cell Transplantation 19Radiosurgery 18Tacrolimus 17Mycophenolic Acid 17Paclitaxel 16HhAntag691 163-ingenyl angelate 16Busulfan 15Introns 14Antilymphocyte Serum 14encorafenib 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Saline Solution × Dermatologic × Clear all
NCT02705352 2020-03-09

5-fluorouracil Versus Placebo in Periocular Full Thickness Skin Grafts

Massachusetts Eye and Ear Infirmary

Phase 2 Completed
1 enrolled 7 charts
Dermatologic

Ectropion, Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡